Valley National Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,065
| Closed | -$36K | – | 893 |
|
|
2020
Q1 | $36K | Buy |
5,065
+1,019
| +25% | +$7.24K | 0.01% | 316 |
|
|
2019
Q4 | $97K | Hold |
4,046
| – | – | 0.02% | 249 |
|
|
2019
Q3 | $109K | Hold |
4,046
| – | – | 0.03% | 234 |
|
|
2019
Q2 | $110K | Buy |
4,046
+981
| +32% | +$26.7K | 0.03% | 225 |
|
|
2019
Q1 | $106K | Sell |
3,065
-981
| -24% | -$33.9K | 0.03% | 230 |
|
|
2018
Q4 | $79K | Sell |
4,046
-391
| -9% | -$7.63K | 0.03% | 229 |
|
|
2018
Q3 | $118K | Buy |
4,437
+1,417
| +47% | +$37.7K | 0.04% | 203 |
|
|
2018
Q2 | $114K | Buy |
3,020
+970
| +47% | +$36.6K | 0.04% | 205 |
|
|
2018
Q1 | $67K | Buy |
2,050
+800
| +64% | +$26.1K | 0.02% | 229 |
|
|
2017
Q4 | $61K | Hold |
1,250
| – | – | 0.02% | 232 |
|
|
2017
Q3 | $68K | Hold |
1,250
| – | – | 0.02% | 229 |
|
|
2017
Q2 | $70K | Hold |
1,250
| – | – | 0.03% | 219 |
|
|
2017
Q1 | $49K | Buy |
1,250
+1,000
| +400% | +$39.2K | 0.02% | 239 |
|
|
2016
Q4 | $6K | Hold |
250
| – | – | ﹤0.01% | 475 |
|
|
2016
Q3 | $6K | Buy |
250
+100
| +67% | +$2.4K | ﹤0.01% | 446 |
|
|
2016
Q2 | $4K | Hold |
150
| – | – | ﹤0.01% | 481 |
|
|
2016
Q1 | $3K | Hold |
150
| – | – | ﹤0.01% | 515 |
|
|
2015
Q4 | $8K | Buy |
+150
| New | +$8K | ﹤0.01% | 411 |
|